ScholarIQanswers from OpenAlex & ORCID
Christos S. Karapetis
ResearcherPublications, citations & collaboration network
Christos S. Karapetis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Christos S. Karapetis have?
ScholarIQindexed works
Christos S. Karapetis has 502 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Christos S. Karapetis have?
ScholarIQcitation count
Christos S. Karapetis has 27,590 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Christos S. Karapetis?
ScholarIQh-index
Christos S. Karapetis has an h-index of 57 in OpenAlex.
What is the i10-index of Christos S. Karapetis?
ScholarIQi10-index
Christos S. Karapetis has an i10-index of 180 in OpenAlex.
What is the ORCID of Christos S. Karapetis?
ScholarIQorcid
The ORCID for Christos S. Karapetis is on the source record.
What is the OpenAlex record for Christos S. Karapetis?
ScholarIQopenalex
The OpenAlex for Christos S. Karapetis is on the source record.
What are the most-cited papers on Christos S. Karapetis?
ScholarIQmost cited works
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Corinne Faivre‐Finn, Martin Reck, Johan Vansteenkiste, David R. Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata‐Ford, John Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
Jeanne Tie, Isaac Kinde, Y. Wang, Hui‐Li Wong, Justin Kelvin Roebert, Michael Christie, Mark Tacey, Rachel Wong, Madhu Singh, Christos S. Karapetis, Jayesh Desai, Ben Tran, R L Strausberg, Luis A. Díaz, Nikolaos G. Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko, Fabrice Barlési, Matthew Krebs, Alice T. Shaw, Filippo de Braud, Christian Rolfo, Myung‐Ju Ahn, Jürgen Wolf, Takashi Seto, Byoung Chul Cho, Manish R. Patel, Chao‐Hua Chiu, Thomas John, Kōichi Goto, Christos S. Karapetis, Hendrick-Tobias Arkenau, Sang-We Kim, Yuichiro Ohe, Yu Li, Young Kwang Chae, Christine H. Chung, Gregory A. Otterson, Haruyasu Murakami, Chia‐Chi Lin, Daniel Shao-Weng Tan, Hans Prenen, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, Robert C. Doebele